Septic shock affects around 750,000 people and kills over 200,000 patients per year within the United States.
Septic shock, which is also known as severe sepsis, occurs when the body’s immune system gets triggered by a bacterial infection or some kind of serious physical injury and starts an inflammatory response that could lead to a dangerously low blood pressure, multiple organ failure and death. Septic shock affects around 750,000 people and kills over 200,000 patients per year within the United States.
Due to the dangers behind this reaction and the difficulty in detecting its onset, researchers from CALS at the University of Wisconsin Madison have come up with a potentially powerful tool that would detect septic shock roughly 12 to 48 hours faster than traditional methods. The team had developed a breath biomarker technology that was patented in 2008. It is currently going through clinical trials and if the results are successful, it could change how doctors treat and handle septic shock.
“If you can detect septic shock earlier, then you can begin to explore ways of treating it earlier,” commented one of the researchers, Mark Cook, who is an animal sciences professor at CALS.
For the research, Cook, who worked with scientist Jordan Sand, focused on the gastrointestinal tract, which has been tied to being the primary site of the massive inflammatory response carried out by the immune system. The team looked at a protein called sPLA2, which has been linked to the chain of events that triggers septic shock, and attempted to interfere with its activity. The protein is known for having two functions as either an enzyme or a signaling molecule.
First, the team blocked sPLA2 from carrying out its signaling function. Even after the protein was inhibited, the researchers found that it made the situation worse for the mice models. The team then created antibodies that would block the protein’s ability to perform as an enzyme. They were shocked to find that by prohibiting sPLA2 to act as an enzyme, the mice models were able to survive.
“We had 100 percent survival across the board,” Sand commented according to Medical Xpress.
The Latest on: Septic Shock
[google_news title=”” keyword=”Septic Shock” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Septic Shock
- Enibarcimab Granted Fast Track Designation for Septic Shockon April 25, 2024 at 5:00 pm
The Food and Drug Administration (FDA) has granted Fast Track designation to enibarcimab for the treatment of septic shock. Enibarcimab (formerly adrecizumab) is a first-in-class non-neutralizing ...
- Conservatives Weave Anti-Abortion Fantasyland To Allow Emergency Room Abortion Banson April 24, 2024 at 10:54 am
The right-wing justices crafted a kind of anti-abortion fantasyland Wednesday where not only do abortion ban exceptions work, but that the narrowest ones will amenably stretch to cover all the ...
- FDA fast tracks enibarcimab for the treatment of septic shockon April 17, 2024 at 7:15 pm
It is believed that modulation of ADM pathway may improve outcomes in patients with septic shock. The Food and Drug Administration has granted Fast Track designation to enibarcimab ...
- A Long-Acting Vasopressin Analog for Septic Shock: Brilliant Idea or Dangerous Folly?on April 17, 2024 at 5:00 pm
The use of terlipressin for hyperdynamic vasodilatory septic shock is intriguing. However, most children in septic shock have hypodynamic cardiac function with high systemic vascular resistance.
- Jail ignored woman’s illness, causing her ‘avoidable’ death, lawyer says. Daughter suingon April 17, 2024 at 7:27 am
Instead of providing medical care to an ailing 60-year-old woman, jail staff in Alabama ignored her worsening illness and released her when she was too sick to recover, according to a new federal ...
- Sepsis signature shifts speed of diagnosison April 10, 2024 at 9:29 am
Sepsis and septic shock patients could experience faster diagnosis and better outcomes thanks to new Western Australian research.
- AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shockon April 10, 2024 at 5:00 am
With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths ...
- AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shockon April 10, 2024 at 1:00 am
With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths ...
- Enibarcimab Granted Fast Track Designation for Septic Shockon April 9, 2024 at 5:00 pm
Subgroup analysis showed that 2 biomarkers, ADM and cDPP3, could help identify patients who would benefit most from enibarcimab therapy. The Food and Drug Administration (FDA) has granted Fast ...
- Woman loses 10 stone after giving up wine when she nearly died from septic shockon April 4, 2024 at 3:59 am
A woman lost 10 stone by giving up wine after almost dying from septic shock. Jo Hurley, 50, went to the doctor in March 2018 for a check up after struggling with heavy periods. During an ...
via Bing News